Why?

New era of Neurodegenerative Disease Treatments Need for development of a more Precise and Friendly Technology that maximizes patient benefits from therapeutic implementation.

How?

Determine Golden Time Window for Alzheimer’s drug implementation using MRI-based Amyloid/Tau burden prediction algorithm.

What?

Software to perform everything from biomarker-based diagnostics to therapeutic suitability etermination using only MRI analysis for health care centers that lack PET protocols.